{
  "path": "/aloha-io/title-19/chapter-329b/section-329b-5/",
  "title": "Substance abuse testing procedures and interpretation of test results",
  "type": "hrs_section",
  "structure": {
    "volume": "6",
    "chapter": "329B",
    "section": "329B-5"
  },
  
  "prev": "https://sammade.github.io/aloha-io/title-19/chapter-329b/section-329b-4/",
  
  
  "next": "https://sammade.github.io/aloha-io/title-19/chapter-329b/section-329b-5_5/",
  
  "context": "ยง329B-5 Substance abuse testing procedures and interpretation of test results. (a) Prior to the collection of any sample for substance abuse testing, the individual to be tested shall receive a written statement of the specific substances to be tested for and a statement that over-the-counter medications or prescribed drugs may result in a positive test result. (b) In accordance with this section, the director shall adopt rules pertaining to: (1) The qualifications, responsibilities, and licensing of the medical review officer; (2) The method of transmittal of laboratory test results and any interpretations of test results to the third party and the tested individual; and (3) The obtaining, disclosure, and confidentiality of substance abuse testing information. &amp;copy; No laboratory, including a substance abuse on-site screening location, may test for any substance not included on the written statement containing the specific substances to be tested for. (d) As used in this section, &amp;ldquo;test results&amp;rdquo; means laboratory test results or the results of substance abuse on-site screening tests. [L 1990, c 236, pt of ยง1; am L 1999, c 206, ยง5; am L 2001, c 53, ยง1] "
}